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Rettion in Cirrhosis
Liver cirrhosis is associated with the altered regulation of sodium and water metabolism 
Disordered regulation of sodium and water transport in the kidney is responsible for altered salt 
and water balance in several pathophysiological states, including cirrhosis. Water reabsorption 
from renal tubules requires not only a favorable solute concentration gradient but also pores for 
the water molecules to exit renal tubules via a family of proteins named aquaporins.  Several 
aquaporins are expressed in the kidney .   Aquaporin-2, recognized as the “vasopressin-
regulated water channel” is expressed in the apical membrane of the collecting duct cells . 
Several studies using experimental models of cirrhosis have reported contrasting results 
regarding aquaporin-2 expression in the kidney. Asahina et al reported increases in aquaporin-2 
following repetitive intraperitoneal injections of carbon tetrachloride .   In contrast, we were 
unable to demonstrate an increase in aquaporin-2 protein abundance in rats with carbon 
tetrachloride-induced cirrhosis . However, these cirrhotic rats with ascites presented an increase 
of   trafficking   of   aquaporin-2   to   the   plasma   membrane   and   interestingly   an   increase   in 
aquaporin-1 in the kidney.   Studies of cirrhosis induced by common bile duct ligation have 
reported a decrease in aquaporin-2 expression in the kidneys of rats with ascites .  These 
differences confirm that the physiological state reached in the two models is very different even 
though both are associated with salt and water retention.   In humans, aquaporin proteins 
research has been done studying urinary aquaporin excretion due to the availability of the urine 
and the ethical conflict of obtaining kidney tissue.  Excretion of aquaporin 2 in urine has been 
shown to correlate with vasopressin-stimulated water retention in experimental animal and 
human models of overhydration and water deprivation (5). Vasopressin has an immediate effect 
on aquaporin 2 concentrations within the apical membrane of collecting duct principal cells by 
stimulating its incorporation from a reservoir of cytoplasmic vesicles and a longer term effect by 
stimulating gene transcription. Given that 3%-4% of renal aquaporin is shed into the urine on a 
daily basis, increased vasopressin activity is reflected by an increase in urinary aquaporin 2 
excretion in experimental animals and in human congestive cardiac failure.    In this study, 
aquaporin-2 excretion was analyzed by immunoblotting in patients with liver cirrhosis during the 
progressive impairment of sodium and water metabolism in cirrhosis.   Twenty-four hour urine 
was collected from healthy volunteers (n=11) and 13 patients with compensated cirrhosis 
(without ascites) and 20 patients with decompensated cirrhosis (11with ascites without renal 
failure and 9 with hepatorenal syndrome).  
1In patients with cirrhosis there was a progressive impairment of liver and renal function 
tests as the disease progressed from compensated cirrhosis, to cirrhosis with ascites without 
renal failure, and hepatorenal syndrome. Likewise, a progressive stimulation of the renin-
aldosterone system, sympathetic nervous system, and vasopressin was observed. Thirteen of 
the 33 patients (39%; 8 with hepatorenal syndrome) had serum sodium concentration below 
normal values (135 mmol/l) and 8 of them (24%) met the criterion of hyponatremia (serum 
sodium equal to or lower than 130 mmol/l). Interestingly, patients with hyponatremia had been 
hyponatremic for a relatively long period of time (average 49 days, range 15 to 60 days).
Urinary aquaporin-2 excretion was reduced in patients with cirrhosis compared to 
healthy subjects. A progressive decrease in urinary aquaporin-2 excretion was observed as the 
severity of cirrhosis increased, from compensated cirrhosis to cirrhosis with ascites, and 
hepatorenal syndrome  (See Fig. 1). Patients with hyponatremia had urinary aquaporin-2 
excretion lower than that of patients without hyponatremia. Vasopressin plasma levels did not 
relate with aquaporin-2 excretion. 
Figures 1: Densitometric analysis of 24-
hour   urine   excretion   of   aquaporin-2 
(Figure   1)   in   healthy   subjects   and   in 
patients with cirrhosis stratified as follows: 
patients   without   ascites,   patients   with 
ascites,   and   patients   with   hepatorenal 
syndrome. * P < 0.05 compared to healthy 
subjects.
Therefore, the results show that in the setting of marked expansion of the extracellular 
fluid volume, reduced serum sodium levels, and increased plasma levels of aldosterone, 
norepinepherine, and vasopressin, characteristic of advanced cirrhosis, there is reduced urinary 
excretion of aquaporin-2. These results contrast with those obtained in patients with congestive 
heart failure, another state of expanded extracellular fluid volume. Studies in humans with 
decompensated congestive heart failure have shown an increased aquaporin-2 excretion  and a 
close correlation between urinary aquaporin-2 and vasopressin levels. Thus, the findings with 
regard to urinary aquaporin-2 excretion are not uniform among the pathophysiological states of 
extracellular volume expansion.  At this point, it is unclear why the two states differ with regard 
to the effect on urinary aquaporin-2 excretion. In general, patients with advanced cirrhosis have 
more chronic hyponatremia and higher plasma vasopressin levels than those with congestive 
heart failure. These differences may explain, at least in part, the different findings in urinary 
aquaporin-2 excretion. It is important to point out that a down-regulation of aquaporin-2 is a 
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                    ascites       ascites     syndromecrucial mechanism of the phenomenon of escape to the effects of vasopressin observed in 
healthy subjects and experimental animals. It has been known for many years  that healthy 
subjects given an infusion of vasopressin, after several initial days of water retention show an 
escape phenomenon characterized by increased urine volume, and a reduction in urine 
osmolality and body weight, despite continued administration of vasopressin. Recent studies 
have demonstrated that this phenomenon is at least in part due to a decrease in aquaporin-2 
water channel expression in the renal collecting duct, which is independent of vasopressin and 
osmolality . The exact mechanism(s) underlying this effect is not known but it may be related to 
increased nitric oxide and/or prostaglandin synthesis in the kidney . As suggested above, the 
reduction in urinary aquaporin-2 excretion found in patients with advanced cirrhosis may 
represent an escape mechanism similar to that found in healthy subjects receiving vasopressin 
to prevent a progressive reduction in serum sodium levels. The existence of a reduced urinary 
excretion   of   aquaporin-2   in   early   stages   of   cirrhosis   before   the   development   of   overt 
hyponatremia is intriguing and deserves further confirmation and investigation. 
Vasopressin (AVP) plasma levels and aquaporin-2 urine 
excretion in LC patients
0,00
2,00
4,00
6,00
0,00 1,00 2,00 3,00
Band density
P
l
a
s
m
a
 
A
V
P
 
R
2 = 0,0546
In conclusions, the results of this study show that in patients with cirrhosis there is a 
decreased urinary aquaporin-2 excretion with respect to that of healthy subjects, particularly in 
patients with hyponatremia and hepatorenal syndrome, which suggests that in cirrhosis there is 
a   down-regulation   of   the   aquaporin-2   expression   in   the   kidney.   This   may   represent   a 
compensatory response to hyponatremia and extracellular fluid volume expansion present in 
patients with cirrhosis. In addition and in contrast with healthy subjects and patients with 
decompensated congestive heart failure, in patients with cirrhosis vasopressin plasma levels do 
not correlate with urinary aquaporin-2 excretion. 
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